Jung Ki-Sun, Oh So Yeon, Jun Hyun Jung, Song Byung-Ki, Park Kwonoh, Oh Sangbo, Kim Jae-Joon, Park Eun-Ju
Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea.
Department of Internal Medicine, Hospice and Palliative Care Team, Pusan National University Yangsan Hospital, Yangsan, Korea.
Ann Palliat Med. 2020 Sep;9(5):2793-2799. doi: 10.21037/apm-20-269. Epub 2020 Aug 26.
Patients and their family have resistance in withholding parenteral nutrition (PN) when patient become unable to intake food in the end-of-life. We aimed to investigate whether the preference for PN is changed after receiving an individual education about the risk and benefit of PN. Additionally, we focused on the preferences of patients and their family and why they prefer it about the nutritional support in the end of life.
This is prospective study. Patients are eligible if they cannot tolerate oral intake and enteral feeding and have Palliative Performance Scale (PPS) ≤50% due to progressive cancer. After informed consent, investigators educated patients and family for an hour using the handouts. Then, patients decided if they will receive PN. Quality of life (QOL) was checked by European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C15-PAL) weekly during 3 weeks. Symptoms related to fluid overloading or dehydration was surveyed weekly also. A social anthropologist participated as an observer or interviewer during whole process of this study.
After education, 12 patients (80%) chose to keep receiving PN and 3 patients (20%) changed their decision from PN to minimal hydration among the 15 patients. More calories were administered to patients who chosen PN (median 1,042.2 vs. 324.3 Kcal/day, P<0.001) for initial 7 days. Overall survival, scores of QLQ-C15-PAL, and symptoms were not different with or without PN. According to the anthropologist, medical staffs regard PN as complex medical treatments, while patients and family recognize it as meal rather than medicine.
Most patients and family prefer to receive PN despite its potential harm and marginal benefit. An in-depth discussion about prognosis and aim of care must be preceded before a decision whether to receive PN can be made.
当患者在临终时无法进食时,患者及其家属在停止肠外营养(PN)方面存在抵触情绪。我们旨在调查在接受关于PN风险和益处的个体化教育后,对PN的偏好是否会改变。此外,我们关注患者及其家属的偏好以及他们在临终时选择某种营养支持方式的原因。
这是一项前瞻性研究。如果患者因进展期癌症无法耐受口服摄入和肠内喂养且姑息治疗表现量表(PPS)≤50%,则符合入选条件。在获得知情同意后,研究人员使用资料手册对患者及其家属进行一小时的教育。然后,患者决定是否接受PN。在3周内每周使用欧洲癌症研究与治疗组织生活质量问卷(EORTC QLQ-C15-PAL)检查生活质量(QOL)。每周还对与液体超负荷或脱水相关的症状进行调查。在本研究的整个过程中,一名社会人类学家作为观察者或访谈者参与。
在15名患者中,接受教育后,12名患者(80%)选择继续接受PN,3名患者(20%)将其决定从PN改为最低限度补液。在最初7天,选择PN的患者接受了更多热量(中位数分别为1042.2千卡/天和324.3千卡/天,P<0.001)。无论是否接受PN,总生存期、QLQ-C15-PAL评分和症状均无差异。根据人类学家的说法,医务人员将PN视为复杂的医疗治疗,而患者及其家属则将其视为膳食而非药物。
尽管PN存在潜在危害且益处有限,但大多数患者及其家属仍倾向于接受PN。在决定是否接受PN之前,必须先对预后和护理目标进行深入讨论。